FDA Clearance Tracker · K153189
Beacon Tissue Marker (SE)
Last checked: Nov 19, 2026Latest source record: Dec 17, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 2015
Substantially Equivalent
Time to decision
44 days
Received Nov 3, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K153189
- Device name
- Beacon Tissue Marker (SE)
- Applicant
- Scion Medical Technologies, LLC
- Applicant location
- Newtown Square, PA
- Received
- Nov 3, 2015
- Decided
- Dec 17, 2015
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Marker, Radiographic, Implantable (NEU)
- Device class
- Class II
- Regulation
- 21 CFR 878.4300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NEU. The earliest in FDA's data is K010348, decided May 3, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K153189
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Scion Medical Technologies, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Star Tissue Marker510(k)
K170905 · Decided Apr 27, 2017 · 30 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K161234 · Decided Aug 3, 2016 · 93 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.